Systematic Review: Efficacy of antiviral therapies for COVID-19.
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials – BMC Infectious Diseases
The post Systematic Review: Efficacy of antiviral therapies for COVID-19. appeared first on Links Medicus.
Meta-analysis of randomized clinical trials: vaccines to prevent COVID-19.
Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials – PLOS One
The post Meta-analysis of randomized clinical trials: vaccines to prevent COVID-19. appeared first on Links Medicus.
Scientists deliberately gave people COVID — here’s what they learnt.
Scientists deliberately gave people COVID — here’s what they learnt – Nature Original Study: [Preprint] Results from the first Covid-19 human challenge study (deliberately infecting individuals in a controlled environment). Related: Perspective | SARS-CoV-2 human challenge studies — establishing the model during an evolving pandemic. World’s first coronavirus “Human Challenge” study receives ethics approval in […]
The post Scientists deliberately gave people COVID — here’s what they learnt. appeared first on Links Medicus.
Why don’t most people with COVID need to test for another 30 days, even if they’re re-exposed?
Why don’t most people with COVID need to test for another 30 days, even if they’re re-exposed? – The Conversation
The post Why don’t most people with COVID need to test for another 30 days, even if they’re re-exposed? appeared first on Links Medicus.
Essay: Tuberculosis in times of COVID-19.
Tuberculosis in times of COVID-19 – Journal of Epidemiology & Community Health Related: Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery. Global tuberculosis progress reversed by COVID-19 pandemic. WHO Report: Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic. How COVID is derailing the […]
The post Essay: Tuberculosis in times of COVID-19. appeared first on Links Medicus.
Data Review: How many people die from air pollution?
Data Review: How many people die from air pollution? – Our World in Data Related: New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution. Short-term exposure to ambient air pollution is associated with increased risk of myocardial infarction mortality 1.8 million excess deaths attributable to urban air pollution in […]
The post Data Review: How many people die from air pollution? appeared first on Links Medicus.
ED management of the post-laryngectomy patient.
ED Management of the Post-Laryngectomy Patient – emDocs
The post ED management of the post-laryngectomy patient. appeared first on Links Medicus.
Review: Management of venous thromboembolism in pregnancy.
Management of venous thromboembolism in pregnancy – Thrombosis Research Related: Management of high-risk pulmonary embolism in pregnancy. Study: Diagnosis of Pulmonary Embolism During Pregnancy Imaging is the only way to diagnose blood clots in pregnancy Prevention and Treatment of Pregnancy-Associated Venous Thromboembolism: Critical Appraisal of International Guidelines
The post Review: Management of venous thromboembolism in pregnancy. appeared first on Links Medicus.
RCT: In patients with cardiogenic shock receiving VA-ECMO, moderate hypothermia did not significantly reduce 30-day mortality. 42% of patients in the moderate hypothermia group died vs. 51% in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.4
Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text) Commentary: Hypothermia vs. Normothermia for Cardiogenic Shock Patients on VA-ECMO – American College of Cardiology Commentary on Twitter In this RCT, for […]
The post RCT: In patients with cardiogenic shock receiving VA-ECMO, moderate hypothermia did not significantly reduce 30-day mortality. 42% of patients in the moderate hypothermia group died vs. 51% in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.45 to 1.13], P = .15). appeared first on Links Medicus.
ERS statement on Long COVID-19 follow-up.
European Respiratory Society Statement on Long COVID-19 Follow-Up – European Respiratory Review
The post ERS statement on Long COVID-19 follow-up. appeared first on Links Medicus.